HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target

Benzinga · 10/11 10:54
HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.